Increase to: 0.5 mg once a week for the next four weeks
Navigating Weight Loss Medications: A Short Course for Dietitians Want to build a deeper, strategic understanding
The presence of GLP-1 receptors in the central nervous system, particularly in the ventral tegmental area (VTA) and nucleus accumbens (NAc), suggests their involvement in reward processing and motivation
AANA developed policies and procedures that align with best available evidence for treating patients taking GLP-1 receptor agonists, which increase insulin synthesis and secretion, suppress glucagon secretion, reduce food intake through appetite suppression, slow gastric emptying, and promote beta-cell proliferation
L-glutathione, capsule shell: hydroxypropyl methylcellulose (HPMC)